Cost comparison · pricing updated September 2026
GLP-1 Savings Calculator
Compare what you're currently paying for your GLP-1 to every other current access path — brand-name with insurance, manufacturer direct-pay, compounded vials, or Foundayo at $149/month self-pay. See your monthly, yearly, and 5-year savings or extra cost.
Quick start — I'm currently paying
Currently paying
Optional — overrides the default above.
Switching to
Optional — overrides the default above.
You would save
$230
per month
66% less$349→$119 per month
Save in 1 yr
$2,760
Save in 2 yrs
$5,520
Save in 5 yrs
$13,800
A vetted tirzepatide partner
Starts above the $119/mo modeled above, so your savings with Eden would be smaller. Compare all tirzepatide providers for the lowest price.
Eden
Compounded tirzepatide · from $129/mo
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
2026 monthly cost reference
Best-effort 2026 monthly cost snapshot for every common GLP-1 access path. Always confirm your actual price with your prescriber, pharmacy, or telehealth provider before committing.
| Access path | Monthly | 1 year | 5 years |
|---|---|---|---|
| Semaglutide | |||
| Wegovy (commercial insurance + savings card) | $25 | $300 | $1,500 |
| Wegovy NovoCare — first 2 months at 0.25 / 0.5 mg (new patients) | $199 | $2,388 | $11,940 |
| Wegovy NovoCare — pen, ongoing (0.25/0.5/1/1.7/2.4 mg) | $349 | $4,188 | $20,940 |
| Wegovy NovoCare — HD pen 7.2 mg | $399 | $4,788 | $23,940 |
| Wegovy NovoCare — oral pill 1.5 mg (starting dose) | $149 | $1,788 | $8,940 |
| Wegovy NovoCare — oral pill 4 mg | $199 | $2,388 | $11,940 |
| Wegovy NovoCare — oral pill 9 mg or 25 mg | $299 | $3,588 | $17,940 |
| Compounded semaglutide (lowest ongoing month-to-month price) | $87 | $1,044 | $5,220 |
| Compounded semaglutide (median listed price) | $179 | $2,148 | $10,740 |
| Tirzepatide | |||
| Zepbound (commercial insurance + savings card) | $25 | $300 | $1,500 |
| Zepbound LillyDirect — 2.5 mg starter | $299 | $3,588 | $17,940 |
| Zepbound LillyDirect — 5 mg | $399 | $4,788 | $23,940 |
| Zepbound LillyDirect — 7.5 mg | $499 | $5,988 | $29,940 |
| Zepbound LillyDirect — 10 / 12.5 / 15 mg maintenance | $699 | $8,388 | $41,940 |
| Zepbound self-pay purchase offer (eligible 7.5–15 mg) | $449 | $5,388 | $26,940 |
| Compounded tirzepatide (lowest ongoing month-to-month price) | $119 | $1,428 | $7,140 |
| Compounded tirzepatide (median listed price) | $249 | $2,988 | $14,940 |
| Orforglipron | |||
| Foundayo / orforglipron (insurance + savings card) | $25 | $300 | $1,500 |
| Foundayo / orforglipron self-pay | $149 | $1,788 | $8,940 |
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Oak
Compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up
Read full review →From $200/mo (starting dose)
Get started →From $99/mo
Get started →From $139/mo (4-month plan rate)
Get started →The 2026 GLP-1 cost landscape
The cost of GLP-1 weight loss therapy varies by an order of magnitude across the access paths available in 2026 — from $25/month with full commercial insurance coverage and a savings card, to $99-$199/month for compounded semaglutide, to $149-$399/month for Wegovy across the NovoCare pen/HD-pen/oral-pill tiers (or $199 for the first 2 months under the new-patient promo), to $299-$699/month for Zepbound across the LillyDirect dose-specific vial tiers, to $1,300+/month list price without any discounts.
The biggest 2026 change is the Foundayo (orforglipron) launch on April 1, 2026 at $149/month self-pay [1]. This is the first FDA-approved branded GLP-1 priced at the same level as compounded semaglutide and tirzepatide, and it has materially compressed the price floor across the entire market.
How the calculator works
Pick your current access path from the “Currently paying” dropdown and the alternative you're considering from the “Switching to” dropdown. The calculator uses the verified 2026 default monthly cost for each option, but you can override either price with the actual amount you're paying or quoted. The result card shows your monthly, yearly, and 5-year savings (or extra cost) for the switch.
Important context for each access path
- Brand-name with insurance + savings card. Both Wegovy and Zepbound have manufacturer savings cards that bring eligible patient costs to $25/month. Eligibility requires commercial insurance (not Medicare or Medicaid), an FDA-on-label prescription, and a prior authorization approval. Without the PA, the savings card doesn't apply.
- Brand-name self-pay direct-pay. Both manufacturers operate direct-pay pharmacies for patients who can't use insurance. NovoCare for Wegovy publishes self-pay tiers by dose (verified September 2026): $199/month for the first 2 monthly fills of the 0.25 mg and 0.5 mg pen for new patients (offer runs through December 31, 2026), $349/month ongoing for the Wegovy pen at 0.25/0.5/1/1.7/2.4 mg doses, $399/month for Wegovy HD 7.2 mg, and for the Wegovy pill $149/month at the 1.5 mg starting dose, $199/month at 4 mg, and $299/month at 9 mg or 25 mg. One month is defined as 1 box of 4 pens or 1 bottle of 30 tablets, and all rates require fulfillment through NovoCare Pharmacy [2]. LillyDirect for Zepbound uses dose-specific vial pricing (effective Dec 1, 2025): $299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg, and $699 for 10/12.5/15 mg maintenance. Lilly's Zepbound Journey Program (effective Feb 23, 2026) offers $449/month for eligible patients on the 7.5–15 mg vials [3]. These are bypass programs that skip the insurance system entirely.
- Compounded semaglutide and tirzepatide. Sold by 503A compounding pharmacies through telehealth providers. The lowest ongoing month-to-month price we track is $87/month for semaglutide (median $179) and $119/month for tirzepatide (median $249), excluding first-month promotions, prepaid plans, microdose plans and prices that need a separate membership. The compounded format is not FDA-approved and quality varies meaningfully between pharmacies. See our compounded bioequivalence investigation and our PCAB accreditation guide for the quality considerations [5].
- Foundayo (orforglipron). The newest entry. $25/month with commercial insurance + savings card, $149/month self-pay through LillyDirect [1]. The self-pay tier is the most aggressive branded GLP-1 pricing in the market and we expect it to drive a meaningful share of the compounded patient population back to brand-name therapy through 2026 and 2027.
Things the calculator doesn't account for
- Insurance deductibles. The $25/month insurance numbers assume you've already met any deductible. Early-year costs may be higher.
- Quantity-discount programs. Many telehealth providers offer multi-month bundles at lower per-month cost.
- Dose escalation pricing. Some manufacturer programs price the lower titration doses differently from the maintenance dose. The defaults here are the maintenance-dose price.
- Switching costs. Switching providers sometimes has one-time fees (intake consultation, shipping). The calculator does not subtract these.
- Quality and reliability differences. The cheapest option is rarely the best. A pharmacy with FDA warning letters, an unaccredited compounding facility, or a telehealth provider that disappears mid-year is cheaper for a reason. See our FDA warning letters database before optimizing purely for price.
Important disclaimer
Pricing is highly volatile in this category and the default monthly costs are best-effort 2026 snapshots from public sources. Always confirm your actual price with your prescriber, pharmacy, or telehealth provider before committing to a switch. Insurance coverage decisions vary by plan and can change year to year. This calculator does not constitute medical or financial advice.
References
- 1.NovoCare self-pay, verified September 2026. $349/month ongoing self-pay for Wegovy pen 0.25, 0.5, 1, 1.7, or 2.4 mg doses through NovoCare Pharmacy. One month = 1 box of 4 pens. novocare.com. 2026. https://www.novocare.com/patient/medicines/wegovy/savings-offer.html
- 2.Lilly press release, April 1, 2026. $149/month for the lowest dose self-pay through LillyDirect. The most affordable branded GLP-1 self-pay option in 2026. investor.lilly.com. 2026. https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill
- 3.Eli Lilly and Company. LillyDirect Zepbound self-pay pricing — 2.5 mg $299, 5 mg $399, 7.5 mg $499, 10/12.5/15 mg $699 (effective Dec 1, 2025); self-pay purchase offer (called the Zepbound Journey Program on LillyDirect) $449 for eligible 7.5–15 mg patients (effective Feb 23, 2026). LillyDirect Zepbound pricing. 2026. https://pricinginfo.lilly.com/zepbound
- 4.Weight Loss Rankings. GLP-1 Compounded Pricing Index 2026. Internal pricing index — live dataset. 2026. https://www.weightlossrankings.org/research/glp1-pricing-index
- 5.U.S. Food and Drug Administration. Compounded Drug Products — 503A and 503B Outsourcing Facility Information. FDA Drug Compounding Resources. 2024. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Related tools and research
- Live GLP-1 pricing index — full dataset across the entire compounded telehealth market
- GLP-1 weight loss calculator — predict your weight loss outcome at each access path
- GLP-1 BMI calculator — see your FDA eligibility and trial-endpoint BMI
- Insurance employer checker — see whether your employer covers Wegovy or Zepbound
- Foundayo approval deep-dive — the new $149/month oral pill that's reshaping the cost floor